Table 5.
Genotype distribution of GST in the subjects of two groups.
| Gene name | Copy number | N (%) | P value | OR (95% CI) | |
|---|---|---|---|---|---|
| Normal control group | Prostate cancer group | ||||
| GSTT1 | 0 | 37 (43.53) | 33 (38.82) | 0.048∗ | 1.56 (1.00–2.38) |
| One | 34 (40.00) | 25 (29.41) | 0.063# | 0.54 (0.35–1.01) | |
| 2 | 11 (12.94) | 16 (18.82) | 1 (reference group) | ||
| >2 | 3 (0.35) | 11 (12.94) | 0.023∗ | 0.43 (0.18–1.17) | |
|
| |||||
| GSTM1 | 0 | 55 (64.71) | 46 (54.12) | 0.032∗ | 0.86 (0.55–1.24) |
| One | 16 (18.82) | 20 (23.53) | 0.41# | 0.79 (0.42–1.56) | |
| 2 | 9 (10.59) | 10 (11.76) | 1 (reference group) | ||
| >2 | 5 (0.59) | 9 (10.59) | 0.034∗ | 0.83 (0.32–2.37) | |
Note. ∗ compared with the remaining three genotype combinations; #compared with the genotype combination with copy number 2.